Cannabis: Best 10-Year Growth Opportunity?

Published on
26 September, 2018
Commodities, Micro, Equities
26 minutes
Asset class

Cannabis: Best 10-Year Growth Opportunity?

Featuring Todd Harrison

Todd Harrison, CIO of CB1 Capital, has been a long-time follower of cannabis stocks, and has often championed their mainstream applications in the pharmaceuticals industry. In this interview with Brian Price, Harrison explains how the growing understanding of the plant’s healthcare applications puts these stocks on the cusp of international and institutional acceptance. Filmed on September 20, 2018 in New York.

Published on
26 September, 2018
Commodities, Micro, Equities
26 minutes
Asset class


  • AZ

    Arthur Z.

    15 10 2018 11:43

    2       1

    If Cannabis has so many medical applications and is entering a massive bull market; why haven’t we seen more advances from countries like Amsterdam where weed has been legal for decades? I definitely see the impact it can have on some medical applications but have you ever tried to hold a conversation with a stonier? Not fun. Are we all thinking that this mass adoption of weed is a good thing? I’m all for legalization but hope I don’t have to deal with more and more burnouts.

  • SL

    Stephen L.

    4 10 2018 11:35

    0       0

    FWIW: TLRY (Tilray) experienced a short squeeze of epic proportions. As I write this, this morning, we are seeing rumblings of it starting again. Whatever hype that existed aside, the price action was fueled in very large part by the inability of market participants, including market makers (I work at one), to settle short without failing. During the worst of the hype, borrow rates were around -450%. The borrow rate has since collapsed and it starting to worsen again. Before you go and say “woah tilray is definitely overvalued”, remember that you are right, but likely for the wrong reasons.

  • TW

    Thomas W.

    30 9 2018 19:33

    0       0
  • PG

    Philippe G.

    29 9 2018 18:39

    4       0

    Yes, please bring this guy back! Covered so much in ~25 mins. Amazing!

  • GO

    Glenn O.

    29 9 2018 03:57

    1       0

    Great interview. Todd See the future, and I for one agree with him.
    There will be peaks and Val lies, but it is a sector that has real blue sky. Be carful what you buy, but the future is very bright.

  • SW

    Steven W.

    27 9 2018 20:43

    0       3

    AMA didn’t know difference between marijuana and cannabis! Give me a break.

  • CD

    Charles D.

    27 9 2018 16:35

    4       0

    Todd Harrison is brilliant...great Wall St. honest broker..has been a visionary in this space...thank you RV.

  • RM

    Russell M.

    27 9 2018 01:14

    1       0

    good interview by brian. an interesting guest helps, but he handled him well.

  • BP

    Brandon P.

    26 9 2018 21:22

    3       1

    Yahtzee, indeed. Well reasoned and well stated Todd! Need some more reasonable voices in this space that are in for the long haul.

  • PM

    Plan M.

    26 9 2018 20:52

    1       0

    I"m watching Pharmacielo which went through a reverse takeover (RTO) earlier this year. This basically means the company will be going public sometime before year end. An RTO occurs when a shell company essentially issues shares to a privately held company, Pharmacielo in this case. And then Pharmacielo becomes a wholly owned entity of this shell company. And this is exactly what Pharmacielo did allowing them to go public without incurring most of the large investment banking fees and associated costs.

    Pharmacielo, which is headquartered in Canada, bought a shell company called AAJ Capital 1 Corp. on the Toronto Venture exchange. Pharmacielo has a distinct advantage in the cultivation market. Sourced from Columbia where natural conditions reduce the costs of growing to a fraction of the costs associated with northern indoor artificial grow operations they have a distribution channel in Canada that will provide a ready market. Canada will be the largest country with full legalization status. Colombia currently grows and processes the majority of cut flowers worldwide and the retooling to grow cannabis is well founded, government supported and in an advanced state...soon to go to market.

  • CR

    Cindy R.

    26 9 2018 20:47

    4       0

    Great interview, very enlightening take on the industry.

  • CB

    C B.

    26 9 2018 14:40

    5       0

    Great interview. I would be curious to hear Todd's thoughts on the differences between the evolution of the cannabis wellness category vs other healthcare sectors where large pharma dominates. Though cannabinoids, terpenes and other natural molecules associated with cannabis may prove to have remarkable health benefits, they are all derived from a commodity that can be grown by anyone, nearly anywhere. I recently shopped for CBD oil online, and the sheer number of producers is overwhelming, all promising high quality, independent lab testing and superior potency. With so little to differentiate, one would think that competition will ultimately drive price towards marginal cost. This tempers my enthusiasm for the sector. (GW Pharma is a different story as they have identified a particular medical application for their product and put it through rigorous clinical trials.)

  • PD

    Peter D.

    26 9 2018 13:21

    2       0

    Commentary suggests this was filmed on August 20, 2018. Should this not read September 20, 2018? Big moves in the interim if not...

  • V!

    Volatimothy !.

    26 9 2018 13:12

    2       0

    I like VBIO for their pro-drugs, children and adults can take them for pain without the psychedelic affects. Beyond specialty applications whats wrong with smoking a joint or eating brownies. Overpaying scientist and corporations to do a farmers job. You can preach wellness but its all about the money. The real key to wellness is prevention.

  • SS

    Steve S.

    26 9 2018 11:30

    13       5

    Cannabis stocks are in bubble territory right now, reminds me of the 3d stocks and bitcoin before they epically crashed.